Integral Health Asset Management’s Alkermes ALKS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.86M | Sell |
100,000
-50,000
| -33% | -$1.43M | 0.26% | 65 |
|
2025
Q1 | $4.95M | Buy |
+150,000
| New | +$4.95M | 0.53% | 48 |
|
2024
Q2 | – | Sell |
-250,000
| Closed | -$6.77M | – | 73 |
|
2024
Q1 | $6.77M | Buy |
250,000
+1,000
| +0.4% | +$27.1K | 0.63% | 56 |
|
2023
Q4 | $6.91M | Sell |
249,000
-26,000
| -9% | -$721K | 0.94% | 47 |
|
2023
Q3 | $7.7M | Sell |
275,000
-9,000
| -3% | -$252K | 1.07% | 38 |
|
2023
Q2 | $8.89M | Buy |
284,000
+105,000
| +59% | +$3.29M | 1.1% | 37 |
|
2023
Q1 | $5.05M | Buy |
+179,000
| New | +$5.05M | 1.02% | 39 |
|
2022
Q4 | – | Sell |
-200,000
| Closed | -$4.47M | – | 61 |
|
2022
Q3 | $4.47M | Sell |
200,000
-61,966
| -24% | -$1.38M | 0.87% | 44 |
|
2022
Q2 | $7.8M | Buy |
261,966
+11,966
| +5% | +$356K | 1.61% | 21 |
|
2022
Q1 | $6.58M | Buy |
250,000
+200,000
| +400% | +$5.26M | 1.71% | 22 |
|
2021
Q4 | $1.16M | Buy |
+50,000
| New | +$1.16M | 0.32% | 62 |
|
2021
Q3 | – | Sell |
-150,000
| Closed | -$3.68M | – | 73 |
|
2021
Q2 | $3.68M | Buy |
+150,000
| New | +$3.68M | 1.01% | 40 |
|
2020
Q2 | – | Sell |
-150,000
| Closed | -$2.16M | – | 60 |
|
2020
Q1 | $2.16M | Buy |
+150,000
| New | +$2.16M | 0.95% | 38 |
|